Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P551 | DOI: 10.1530/endoabs.110.P551

1Endocrinologie Pédiatrique, Centre de Référence Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Robert-Debré APHP Nord, Paris 75019, France, Université Paris-Cité, Faculté de Santé, UFR de Médecine, Paris 75005, France, PARIS, France; 2Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, 94276 Le Kremlin-Bicêtre, France, Le Kremlin-Bicêtre, France; 3Inserm U1292, CEA, UGA, 38054, Grenoble, France; 4Inserm U1292, CEA, UGA, 38054, Grenoble, France, Grenoble, France; 5Service de Génétique Moléculaire, Pharmacogénétique et Hormonologie, Hôpital Bicêtre APHP Paris Saclay, Le Kremlin Bicêtre 94270, France, Le Kremlin-Bicêtre, France; 6Department of Neonatal Pediatrics, Poissy Saint Germain Hospital, Versailles Saint Quentin en Yvelines University, Poissy, France, Poissy, France; 7Institut du Cerveau, Hôpital de la Pitié-Salpêtrière, 47 boulevard de l’Hôpital, 75646, Paris, France, Paris, France; 8Service d’Endocrinologie et des Maladies de la Reproduction, Hôpital Bicêtre APHP Paris Saclay, Le Kremlin-Bicêtre 94270, France, Le Kremlin-Bicêtre, France.


JOINT3850

Aldosterone regulates sodium homeostasis by binding to the Mineralocorticoid Receptor (MR). We have previously identified a critical temporal window during renal development with a down regulation of MR expression at birth, explaining the physiological sodium losses observed in newborns. However, the molecular mechanisms governing MR expression remain unclear. Here, we report the involvement of two microRNAs (miRNAs), miR-409-3p and miR-431-5p, in regulating MR expression during early renal development. Using miRNA sequencing, we identified these miRNAs as upregulated on mouse postnatal day 0 (D0) compared to day 8 (D8). RT-qPCR validated their differential expression, while luciferase reporter assays confirmed their functional interaction with MR transcripts. Functional studies using miRNA mimics and inhibitors revealed that miR-409-3p and miR-431-5p modulate MR expression and signaling in primary renal cell cultures. Specifically, their increased expression at D0 destabilizes MR transcripts and decreases MR expression and signaling, while their decreased expression at D8 leads to MR stabilization and enhanced mineralocorticoid signaling. Notably, digital droplet PCR (ddPCR) analysis of neonatal urine samples from the PREMALDO cohort demonstrated that these miRNAs are highly expressed at birth in humans but decrease gradually postnatally. Our findings identify miR-409-3p and miR-431-5p as key regulators of MR expression and mineralocorticoid signaling during renal development. These miRNAs could serve as potential predictive and non-invasive biomarkers of renal maturity and mineralocorticoid signaling efficiency notably in premature infants that have exacerbated sodium losses due to mineralocorticoid signaling defect in the neonatal period.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches